Petmed Express (PETS) Cash & Equivalents (2010 - 2025)

Petmed Express has reported Cash & Equivalents for 16 years, with the latest figure at $26.9 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents fell 46.28% year-over-year to $26.9 million; the trailing twelve-month figure through Dec 2025 stood at $26.9 million (down 46.28% YoY), and the FY2025 full-year result was $54.7 million, down 1.05% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $26.9 million, down from $36.1 million in the prior quarter.
• The five-year high for Cash & Equivalents was $118.7 million in Q1 2021, with the low at $26.9 million in Q4 2025.
• Historically, Cash & Equivalents has averaged $74.6 million across 5 years, with a median of $58.4 million in 2023.
• Annual changes were most pronounced in 2021 — Cash & Equivalents rose 28.79% — and 2023, when it sank 51.77%.
• Petmed Express' Cash & Equivalents stood at $108.9 million in 2021, then decreased by 5.95% to $102.4 million in 2022, then slumped by 51.77% to $49.4 million in 2023, then advanced by 1.42% to $50.1 million in 2024, then slumped by 46.28% to $26.9 million in 2025.
• The last three Cash & Equivalents figures came in at $26.9 million (Q4 2025), $36.1 million (Q3 2025), and $41.1 million (Q2 2025), per Business Quant data.